Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Loulergue

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Infection|August 8, 2013
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter studyPierre Loulergue, Florence Tubach, Dominique Salmon, et al.
Investigational New Drugs|November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitorsPierre Loulergue, Mansouria Merad, Romain Coriat, et al.
Plos One|August 5, 2016
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVincent Muturi-Kioi, David Lewis, Odile Launay, et al.
Rheumatology (Oxford, England)|January 25, 2011
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnessesCecile Marchand-Janssen, Pierre Loulergue, Luc Mouthon, et al.
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Journal of Autoimmunity|April 7, 2017
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsisAnthony Lopez, Xavier Mariette, Hervé Bachelez, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH <i>Shigella sonnei</i> 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 23, 2016
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter studyPaul Loubet, Nezha Samih-Lenzi, Florence Galtier, et al.
The Journal of Infectious Diseases|June 2, 2011
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trialOdile Launay, Corinne Desaint, Christine Durier, et al.
Blood|July 18, 2012
Pivotal role of M-DC8⁺ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial productsCharles-Antoine Dutertre, Sonia Amraoui, Annalisa DeRosa, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Infection|August 8, 2013
Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter studyPierre Loulergue, Florence Tubach, Dominique Salmon, et al.
Investigational New Drugs|November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitorsPierre Loulergue, Mansouria Merad, Romain Coriat, et al.
Plos One|August 5, 2016
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic ReviewVincent Muturi-Kioi, David Lewis, Odile Launay, et al.
Rheumatology (Oxford, England)|January 25, 2011
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnessesCecile Marchand-Janssen, Pierre Loulergue, Luc Mouthon, et al.
The Journal of Clinical Investigation|March 8, 2019
Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccinationEléna Gonçalves, Olivia Bonduelle, Angèle Soria, et al.
Journal of Autoimmunity|April 7, 2017
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsisAnthony Lopez, Xavier Mariette, Hervé Bachelez, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH <i>Shigella sonnei</i> 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 23, 2016
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter studyPaul Loubet, Nezha Samih-Lenzi, Florence Galtier, et al.
The Journal of Infectious Diseases|June 2, 2011
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trialOdile Launay, Corinne Desaint, Christine Durier, et al.
Blood|July 18, 2012
Pivotal role of M-DC8⁺ monocytes from viremic HIV-infected patients in TNFα overproduction in response to microbial productsCharles-Antoine Dutertre, Sonia Amraoui, Annalisa DeRosa, et al.
Pageof 7